Analysis and variability of TGFβ measurements in cancer patients with skeletal metastases
Peter J O’Brien1, Rajeev Ramanathan2, Jonathan M Yingling1, Jose Baselga3, Mace L Rothenberg4, Michael Carducci5, Thomas Daly1, Dorothy Adcock2, Michael Lahn11Eli Lilly and Company Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA; 2Esoterix Coagulation, Aurora, CO,...
Enregistré dans:
Auteurs principaux: | Peter J O’Brien, Rajeev Ramanathan, Jonathan M Yingling, Jose Baselga, Mace L Rothenberg, et al |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2008
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/eb6a465b749d4abc800f350f26a9a6fa |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Role of TGF-β in Bone Metastases
par: Trupti Trivedi, et autres
Publié: (2021) -
An update on the toxicity of Aβ in Alzheimer’s disease
par: Jürgen Götz, et autres
Publié: (2008) -
Effective screen for amyloid β aggregation inhibitor using amyloid β-conjugated gold nanoparticles
par: Sun-Ho Han, et autres
Publié: (2010) -
Effect of 17β-estradiol on olfactory bulbectomy-induced oxidative stress and behavioral changes in rats
par: Inmaculada Tasset, et autres
Publié: (2008) -
Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors
par: Stopeck AT, et autres
Publié: (2012)